IP Library Granted Patent US 10,876,139
Granted Patent B2
US 10,876,139 · App. 16/423,402 · Granted Dec 29, 2020

Host cells and methods for producing diacid compounds

Inventors: Robert W. Haushalter (Emeryville, CA); Jay D. Keasling (Berkeley, CA)
Assignee: The Regents of the University of California
C12P7/44C12N9/1007C12N9/16C12P7/6409C12P7/6436C12P17/08C12Y201/01197C12Y301/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,876,139
App. No.
16/423,402
Granted
Dec 29, 2020
Kind
B2
Abstract

The present invention provides for a genetically modified host cell and related methods and materials for the biocatalytic production of an α,ω-dicarboxylic acids (DCAs) and/or mono-methyl ester derivatives of dicarboxylic acids (DCAMMEs).

Claims (45)

1. A recombinant genetically modified host cell comprising: (a) a polypeptide having an amino acid sequence that has at least 70% amino acid sequence identity to any one of SEQ ID NO:1-9 wherein the polypeptide is capable of catalyzing a methyl transfer to an acyl-ACP species with a free carboxylate group distal to the thioester bond to form a first intermediate compound, (b) enzymes having enzymatic activities that elongates the first intermediate molecule to form a second intermediate compound, wherein the enzymes of step (b) are fatty acid synthase (FAS), and (c) a cytosolic thiosterase (′TesA) that catalyzes a release of the first or second intermediate molecule from the ACP through thioester hydrolysis to form an α,ω-dicarboxylic acids (DCAs) having the chemical formula:

and/or a mono-methyl ester derivative of dicarboxylic acids (DCAMME) having the chemical formula:

wherein n is an integer from 1 to 30; wherein the recombinant genetically modified host cell is reduced or lacks a pimeloyl-acyl carrier protein methyl ester esterase (BioH) enzymatic activity, wherein the recombinant genetically modified host cell lacks pimoeloyl-acyl carrier protein methyl ester esterase (BioH) enzymatic activity or is reduced for BioH enzymatic activity compared to an unmodified host cell.

2. The recombinant genetically modified host cell of claim 1 , wherein the ′TesA catalyzes the release of the first or second intermediate molecule from the ACP through thioester hydrolysis to form the DCAMME having the chemical formula:

wherein n is an integer from 1 to 30.

3. The recombinant genetically modified host cell of claim 1 , wherein the ′TesA catalyzes the release of the first or second intermediate molecule from the ACP through thioester hydrolysis to form the DCA having the chemical formula:

wherein n is an integer from 1 to 30.

4. The recombinant genetically modified host cell of claim 1 , wherein the DCA comprises a main carbon chain with an odd number of carbon atoms.

5. The recombinant genetically modified host cell of claim 4 , wherein the DCA is a C7 diacid, C9 diacid, C11 diacid, C13 diacid, C15 diacid, C17 diacid, C19 diacid, C21 diacid, C23 diacid, or C25 diacid.

6. The recombinant genetically modified host cell of claim 5 , wherein the DCA is a C7 diacid, C9 diacid, C11 diacid, C13 diacid, or C15 diacid.

7. The recombinant genetically modified host cell of claim 6 , wherein the DCA is a C7 diacid.

8. The recombinant genetically modified host cell of claim 6 , wherein the DCA is a C9 diacid.

9. The recombinant genetically modified host cell of claim 6 , wherein the DCA is a C11 diacid.

10. The recombinant genetically modified host cell of claim 6 , wherein the DCA is a C13 diacid.

11. The recombinant genetically modified host cell of claim 6 , wherein the DCA is a C15 diacid.

12. The recombinant genetically modified host cell of claim 1 , wherein the DCA comprises a main carbon chain with an even number of carbon atoms.

13. The recombinant genetically modified host cell of claim 12 , wherein the DCA is a C6 diacid, C8 diacid, C10 diacid, C12 diacid, C14 diacid, C16 diacid, C18 diacid, C20 diacid, C22 diacid, C24 diacid, or C26 diacid.

14. The recombinant genetically modified host cell of claim 13 , wherein the DCA is a C6 diacid, C8 diacid, C10 diacid, C12 diacid, C14 diacid, C16 diacid.

15. The recombinant genetically modified host cell of claim 14 , wherein the DCA is a C6 diacid.

16. The recombinant genetically modified host cell of claim 14 , wherein the DCA is a C8 diacid.

17. The recombinant genetically modified host cell of claim 14 , wherein the DCA is a C10 diacid.

18. The recombinant genetically modified host cell of claim 14 , wherein the DCA is a C12 diacid.

19. The recombinant genetically modified host cell of claim 14 , wherein the DCA is a C14 diacid.

20. The recombinant genetically modified host cell of claim 14 , wherein the DCA is a C16 diacid.

21. The recombinant genetically modified host cell of claim 1 , wherein the host cell is a yeast cell or a bacterial cell.

22. The recombinant genetically modified host cell of claim 21 , wherein the host cell is an Escherichia or Bacillus cell.

23. The recombinant genetically modified host cell of claim 1 , wherein the polypeptide has an amino acid sequence that has at least 80% amino acid sequence identity to any one of SEQ ID NO:1-9.

24. The recombinant genetically modified host cell of claim 23 , wherein the polypeptide has an amino acid sequence that has at least 90% amino acid sequence identity to any one of SEQ ID NO:1-9.

25. The recombinant genetically modified host cell of claim 24 , wherein the polypeptide has an amino acid sequence that has at least 95% amino acid sequence identity to any one of SEQ ID NO:1-9.

26. The recombinant genetically modified host cell of claim 25 , wherein the polypeptide has an amino acid sequence that has at least 99% amino acid sequence identity to any one of SEQ ID NO:1-9.

27. The recombinant genetically modified host cell of claim 1 , wherein the polypeptide has an amino acid sequence that has at least 70% amino acid sequence identity to SEQ ID NO:8.

28. The recombinant genetically modified host cell of claim 1 , wherein the polypeptide has a Y at position 18, a D at position 99, and an E at position 153, wherein each position corresponds to the position in SEQ ID NO:8.

29. The recombinant genetically modified host cell of claim 28 , wherein the polypeptide has a K at position 4, a F at position 11, an A at position 22, a Q at position 25, an L at position 32, a G at position 62, a G at position 64, an A at position 73, an A at position 84, an E at position 101, a D at position 110, a S at position 114, a Q at position 119, a W at position 120, an L at position 131, a G at position 139, a F at position 143, a T at position 145, a G at position 219, and a G at position 251, wherein each position corresponds to the position in SEQ ID NO:8.

30. A method for producing dicarboxylic acids (DCAs) and mono-methyl ester derivatives of dicarboxylic acids (DCAMMEs) comprising:

(a) providing the genetically modified host cell of claim 1 , and

(b) culturing or growing the genetically modified host cell such that a DCA and/or a DCAMME is produced.

31. The method of claim 30 , further comprising (c) separating the DCA and/or the DCAMME from the genetically modified host cell.

32. The method of claim 30 , further comprising (d) polymerizing the DCA and/or the DCAMME into a polyester or polyamide polymer.

33. The method of claim 32 , wherein the polymerizing step comprises reacting the DCA with a diamine to produce a nylon.

34. The method of claim 33 , wherein the diamine is an alkane diamine.

35. The method of claim 32 , wherein the polymerizing step comprises reacting the DCA with a dialcohol to produce a polyester.

36. The method of claim 35 , wherein the dialcohol is an alkane diol.

37. The method of claim 36 , wherein the alkane diol is ethylene glycol, propane diol, or butanediol.

38. The method of claim 31 , further comprises converting the DCA into a macrocyclic musk.

39. The method of claim 38 , wherein the DCA is brassylic acid and the macrocyclic musk is ethylene brassylate.

Assignments (2)
CONFIRMATORY LICENSE Recorded Apr 27, 2020
From: UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB
To: UNITED STATES DEPARTMENT OF ENERGY
Reel/Frame 052499/0439 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 28, 2019
From: HAUSHALTER, ROBERT W.; KEASLING, JAY D.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 049291/0332 →
Continuity (3)
Continuation 15067121 · Mar 10, 2016
Provisional Application 62130971 · Mar 10, 2015
Related Publication 20190309331A1 · Oct 10, 2019